{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:40:58Z","timestamp":1757619658793,"version":"3.44.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009367","name":"Mansoura University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009367","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Despite the crucial role of kidney biopsy in the management of various kidney diseases, it has inherent limitations. Therefore, the search for non-invasive biomarkers as alternative diagnostic and prognostic tools is warranted. The aim of this study was to assess the association between soluble urokinase plasminogen activator receptor (suPAR) and epidermal growth factor (EGF) levels and various histopathological findings in patients undergoing kidney biopsy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This cross-sectional study involved patients who underwent kidney biopsies over a period of nine months. On the day of the biopsy, sociodemographic, clinical, and routine laboratory data were collected from patients\u2019 medical records. Urine samples were obtained for measurement of urinary suPAR, EGF, and creatinine levels. Kidney biopsies were reviewed and interpreted by an expert nephropathologist.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 82 patients (36 males) with a mean age of 36 years were included. The most common histopathological diagnosis was lupus nephritis (30.5%), followed by end-stage kidney disease (12%). Glomerulosclerosis (GS), tubular atrophy (TA), and interstitial fibrosis (IF) were present in 66%, 62%, and 74% of patients, respectively. Additionally, tubular injury, detached podocytes, and vascular fibrointimal thickening were observed in 30%, 5%, and 22% of patients, respectively. Both suPAR and EGF levels showed no statistically significant differences among varying degrees of GS, TA, and IF. However, urinary suPAR\/creatinine was significantly higher in patients with tubular injury than in those without (<jats:italic>p<\/jats:italic>\u2009=\u20090.003). Its cut-off value to predict tubular injury was 0.08 with moderate sensitivity and specificity. Urinary EGF\/creatinine was significantly lower in patients with detached podocytes than in those without (<jats:italic>p<\/jats:italic>\u2009=\u20090.028), whereas it was significantly higher in patients with vascular fibrointimal thickening than in those without (<jats:italic>p<\/jats:italic>\u2009=\u20090.043). Its cut-off value to predict vascular fibrointimal thickening was 0.88 with low-to-moderate sensitivity and moderate specificity.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Both urinary suPAR\/creatinine and urinary EGF\/creatinine ratios were not associated with either glomerulosclerosis or IF\/TA, and therefore, cannot substitute for kidney biopsy in the assessment of kidney fibrosis. Higher urinary suPAR was associated with tubular injury, suggesting its potential link with acute tubular damage. In contrast, lower urinary EGF levels were found to be associated with podocyte detachment. Additionally, increased urinary EGF was associated with vascular fibrointimal thickening, suggesting a possible role in vascular remodeling. These findings highlight associations that warrant further investigation in longitudinal studies.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12882-025-04351-5","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T08:06:44Z","timestamp":1753430804000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of soluble urokinase plasminogen activator receptor and epidermal growth factor with histopathological findings of kidney biopsy: a single-center study"],"prefix":"10.1186","volume":"26","author":[{"given":"Eman","family":"Nagy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Almenshawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa","family":"Abdelsalam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed M. Abd","family":"Elwahab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ola M.","family":"Gharbia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma","family":"El-Husseiny\u00a0Moustafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagy Sayed","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nora A.","family":"Khreba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"issue":"12","key":"4351_CR1","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.3390\/diagnostics11122186","volume":"11","author":"A Granata","year":"2021","unstructured":"Granata A, Distefano G, Pesce F, Battaglia Y, Suavo Bulzis P, Venturini M, Palmucci S, Cantisani V, Basile A, Gesualdo L. Performing an ultrasound-guided percutaneous needle kidney biopsy: an up-to-date procedural review. Diagnostics. 2021;11(12):2186.","journal-title":"Diagnostics"},{"issue":"8","key":"4351_CR2","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1093\/ndt\/gfp073","volume":"24","author":"B Waldo","year":"2009","unstructured":"Waldo B, Korbet SM, Freimanis MG, Lewis EJ. The value of post-biopsy ultrasound in predicting complications after percutaneous renal biopsy of native kidneys. Nephrol Dialysis Transplantation. 2009;24(8):2433\u20139.","journal-title":"Nephrol Dialysis Transplantation"},{"issue":"3","key":"4351_CR3","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1053\/j.ajkd.2018.10.011","volume":"73","author":"RL Luciano","year":"2019","unstructured":"Luciano RL, Moeckel GW. Update on the native kidney biopsy: core curriculum 2019. Am J Kidney Dis. 2019;73(3):404\u201315.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"4351_CR4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.2215\/CJN.0000000000000309","volume":"19","author":"D Marchel","year":"2024","unstructured":"Marchel D, Trachtman H, Larkina M, Helmuth M, Lai Yee JY, Fermin D, Bomback AS, Canetta PA, Gipson DS, Mottl AK, et al. The significance of hematuria in podocytopathies. Clin J Am Soc Nephrol. 2024;19(1):56\u201366.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"4351_CR5","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41572-020-0196-7","volume":"6","author":"JB Kopp","year":"2020","unstructured":"Kopp JB, Anders H-J, Susztak K, Podest\u00e0 MA, Remuzzi G, Hildebrandt F, Romagnani P. Podocytopathies. Nat Reviews Disease Primers. 2020;6(1):68.","journal-title":"Nat Reviews Disease Primers"},{"issue":"1","key":"4351_CR6","first-page":"3765608","volume":"2016","author":"E K\u00f6nigshausen","year":"2016","unstructured":"K\u00f6nigshausen E, Sellin L. Circulating permeability factors in primary focal segmental glomerulosclerosis: a review of proposed candidates. Biomed Res Int. 2016;2016(1):3765608.","journal-title":"Biomed Res Int"},{"key":"4351_CR7","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s00424-017-2026-7","volume":"469","author":"M Zeier","year":"2017","unstructured":"Zeier M, Reiser J. SuPAR and chronic kidney disease\u2014A podocyte story. Pfl\u00fcgers Archiv-European J Physiol. 2017;469:1017\u201320.","journal-title":"Pfl\u00fcgers Archiv-European J Physiol"},{"issue":"1","key":"4351_CR8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1681\/ASN.2013111213","volume":"26","author":"T-H Yoo","year":"2015","unstructured":"Yoo T-H, Pedigo CE, Guzman J, Correa-Medina M, Wei C, Villarreal R, Mitrofanova A, Leclercq F, Faul C, Li J. Sphingomyelinase-like phosphodiesterase 3b expression levels determine podocyte injury phenotypes in glomerular disease. J Am Soc Nephrol. 2015;26(1):133\u201347.","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"4351_CR9","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/nm.2411","volume":"17","author":"C Wei","year":"2011","unstructured":"Wei C, El Hindi S, Li J, Fornoni A, Goes N, Sageshima J, Maiguel D, Karumanchi SA, Yap H-K, Saleem M. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med. 2011;17(8):952\u201360.","journal-title":"Nat Med"},{"issue":"7","key":"4351_CR10","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/TP.0b013e31829eda4f","volume":"96","author":"N Alachkar","year":"2013","unstructured":"Alachkar N, Wei C, Arend LJ, Jackson AM, Racusen LC, Fornoni A, Burke G, Rabb H, Kakkad K, Reiser J. Podocyte effacement closely links to SuPAR levels at time of posttransplantation focal segmental glomerulosclerosis occurrence and improves with therapy. Transplantation. 2013;96(7):649\u201356.","journal-title":"Transplantation"},{"issue":"3","key":"4351_CR11","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.devcel.2020.05.026","volume":"54","author":"AG Marneros","year":"2020","unstructured":"Marneros AG. AP-2\u03b2\/KCTD1 control distal nephron differentiation and protect against renal fibrosis. Dev Cell. 2020;54(3):348\u201366. e345.","journal-title":"Dev Cell"},{"issue":"10","key":"4351_CR12","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1093\/ndt\/gfaa208","volume":"36","author":"JV Norvik","year":"2021","unstructured":"Norvik JV, Harskamp LR, Nair V, Shedden K, Solbu MD, Eriksen BO, Kretzler M, Gansevoort RT, Ju W, Melsom T. Urinary excretion of epidermal growth factor and rapid loss of kidney function. Nephrol Dialysis Transplantation. 2021;36(10):1882\u201392.","journal-title":"Nephrol Dialysis Transplantation"},{"issue":"9","key":"4351_CR13","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.7150\/thno.31424","volume":"9","author":"L Xu","year":"2019","unstructured":"Xu L, Li X, Zhang F, Wu L, Dong Z, Zhang D. EGFR drives the progression of AKI to CKD through HIPK2 overexpression. Theranostics. 2019;9(9):2712.","journal-title":"Theranostics"},{"issue":"7","key":"4351_CR14","doi-asserted-by":"publisher","first-page":"100846","DOI":"10.1016\/j.xkme.2024.100846","volume":"6","author":"M Postalcioglu","year":"2024","unstructured":"Postalcioglu M, Scherzer R, Ix JH, Jacobs DR Jr., Lewis CE, Vaigankar S, Estrella MM, Gutierrez OM, Shlipak MG. Urine epidermal growth factor and kidney function decline in Middle-Aged adults. Kidney Med. 2024;6(7):100846.","journal-title":"Kidney Med"},{"issue":"316","key":"4351_CR15","doi-asserted-by":"publisher","first-page":"ra316193","DOI":"10.1126\/scitranslmed.aac7071","volume":"7","author":"W Ju","year":"2015","unstructured":"Ju W, Nair V, Smith S, Zhu L, Shedden K, Song PX, Mariani LH, Eichinger FH, Berthier CC, Randolph A. Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker. Sci Transl Med. 2015;7(316):ra316193\u2013316193.","journal-title":"Sci Transl Med"},{"issue":"5","key":"4351_CR16","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1056\/NEJMoa1911481","volume":"382","author":"SS Hayek","year":"2020","unstructured":"Hayek SS, Leaf DE, Samman Tahhan A, Raad M, Sharma S, Waikar SS, Sever S, Camacho A, Wang X, Dande RR. Soluble urokinase receptor and acute kidney injury. N Engl J Med. 2020;382(5):416\u201326.","journal-title":"N Engl J Med"},{"issue":"1","key":"4351_CR17","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nm.4242","volume":"23","author":"E Hahm","year":"2017","unstructured":"Hahm E, Wei C, Fernandez I, Li J, Tardi NJ, Tracy M, Wadhwani S, Cao Y, Peev V, Zloza A. Bone marrow-derived immature myeloid cells are a main source of Circulating SuPAR contributing to proteinuric kidney disease. Nat Med. 2017;23(1):100\u20136.","journal-title":"Nat Med"},{"issue":"3","key":"4351_CR18","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/ki.2014.346","volume":"87","author":"JM Spinale","year":"2015","unstructured":"Spinale JM, Mariani LH, Kapoor S, Zhang J, Weyant R, Song PX, Wong HN, Troost JP, Gadegbeku CA, Gipson DS. A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease. Kidney Int. 2015;87(3):564\u201374.","journal-title":"Kidney Int"},{"issue":"8","key":"4351_CR19","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1681\/ASN.2013040425","volume":"25","author":"D Cathelin","year":"2014","unstructured":"Cathelin D, Placier S, Ploug M, Verpont M-C, Vandermeersch S, Luque Y, Hertig A, Rondeau E, Mesnard L. Administration of Recombinant soluble urokinase receptor per se is not sufficient to induce podocyte alterations and proteinuria in mice. J Am Soc Nephrol. 2014;25(8):1662\u20138.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"4351_CR20","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s10157-024-02465-y","volume":"28","author":"A Fukuda","year":"2024","unstructured":"Fukuda A, Sato Y, Shibata H, Fujimoto S, Wiggins RC. Urinary podocyte markers of disease activity, therapeutic efficacy, and long-term outcomes in acute and chronic kidney diseases. Clin Exp Nephrol. 2024;28(6):496\u2013504.","journal-title":"Clin Exp Nephrol"},{"key":"4351_CR21","doi-asserted-by":"crossref","unstructured":"Harris RC, Chung E, Coffey RJ. EGF receptor ligands. EGF Receptor Family 2003:3\u201314.","DOI":"10.1016\/B978-012160281-9\/50002-5"},{"issue":"12","key":"4351_CR22","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1097\/01.ASN.0000098681.56240.1A","volume":"14","author":"Z Wang","year":"2003","unstructured":"Wang Z, Chen J-K, Wang S-w, Moeckel G, Harris RC. Importance of functional EGF receptors in recovery from acute nephrotoxic injury. J Am Soc Nephrol. 2003;14(12):3147\u201354.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"4351_CR23","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1159\/000524586","volume":"53","author":"C Cortvrindt","year":"2022","unstructured":"Cortvrindt C, Speeckaert R, Delanghe JR, Speeckaert MM. Urinary epidermal growth factor: a promising next generation biomarker in kidney disease. Am J Nephrol. 2022;53(5):372\u201387.","journal-title":"Am J Nephrol"},{"issue":"1","key":"4351_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/ki.2012.43","volume":"82","author":"J Chen","year":"2012","unstructured":"Chen J, Chen J-K, Harris RC. Deletion of the epidermal growth factor receptor in renal proximal tubule epithelial cells delays recovery from acute kidney injury. Kidney Int. 2012;82(1):45\u201352.","journal-title":"Kidney Int"},{"key":"4351_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/scrt314","volume":"4","author":"D Li","year":"2013","unstructured":"Li D, Wang N, Zhang L, Hanyu Z, Xueyuan B, Fu B, Shaoyuan C, Zhang W, Xuefeng S, Li R. Mesenchymal stem cells protect podocytes from apoptosis induced by high glucose via secretion of epithelial growth factor. Stem Cell Res Ther. 2013;4:1\u201311.","journal-title":"Stem Cell Res Ther"},{"key":"4351_CR26","doi-asserted-by":"crossref","unstructured":"Rayego-Mateos S, Rodrigues-Diez R, Morgado-Pascual JL, Valentijn F, Valdivielso JM, Goldschmeding R, Ruiz-Ortega M. Role of epidermal growth factor receptor (EGFR) and its ligands in kidney inflammation and damage. Mediat Inflamm 2018;2018(1):8739473.","DOI":"10.1155\/2018\/8739473"},{"issue":"10","key":"4351_CR27","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1161\/CIRCRESAHA.108.171728","volume":"102","author":"H Zhang","year":"2008","unstructured":"Zhang H, Sunnarborg SW, McNaughton KK, Johns TG, Lee DC, Faber JE. Heparin-binding epidermal growth factor\u2013like growth factor signaling in flow-induced arterial remodeling. Circul Res. 2008;102(10):1275\u201385.","journal-title":"Circul Res"},{"issue":"2","key":"4351_CR28","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1161\/hy0202.103076","volume":"39","author":"CM Reynolds","year":"2002","unstructured":"Reynolds CM, Eguchi S, Frank GD, Motley ED. Signaling mechanisms of heparin-binding epidermal growth factor-like growth factor in vascular smooth muscle cells. Hypertension. 2002;39(2):525\u20139.","journal-title":"Hypertension"},{"issue":"4","key":"4351_CR29","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S1359-6101(00)00013-7","volume":"11","author":"R Iwamoto","year":"2000","unstructured":"Iwamoto R, Mekada E. Heparin-binding EGF-like growth factor: a juxtacrine growth factor. Cytokine Growth Factor Rev. 2000;11(4):335\u201344.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"6","key":"4351_CR30","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1006\/jmcc.1997.0399","volume":"29","author":"TJ Reape","year":"1997","unstructured":"Reape TJ, Wilson VJ, Kanczler JM, Ward JP, Burnand KG, Thomas CR. Detection and cellular localization of heparin-binding epidermal growth factor-like growth factor mRNA and protein in human atherosclerotic tissue. J Mol Cell Cardiol. 1997;29(6):1639\u201348.","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"4351_CR31","doi-asserted-by":"publisher","first-page":"F179","DOI":"10.1016\/S0304-419X(97)00024-3","volume":"1333","author":"G Raab","year":"1997","unstructured":"Raab G, Klagsbrun M. Heparin-binding EGF-like growth factor. Biochim Et Biophys Acta (BBA)-Reviews Cancer. 1997;1333(3):F179\u201399.","journal-title":"Biochim Et Biophys Acta (BBA)-Reviews Cancer"},{"issue":"6","key":"4351_CR32","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1038\/ki.1996.521","volume":"50","author":"E Ranieri","year":"1996","unstructured":"Ranieri E, Gesualdo L, Petrarulo F, Schena FP. Urinary IL-6\/EGF ratio: a useful prognostic marker for the progression of renal damage in IgA nephropathy. Kidney Int. 1996;50(6):1990\u20132001.","journal-title":"Kidney Int"},{"issue":"5","key":"4351_CR33","doi-asserted-by":"publisher","first-page":"e22286","DOI":"10.1096\/fj.202101837R","volume":"36","author":"AM Zeid","year":"2022","unstructured":"Zeid AM, Lamontagne JO, Zhang H, Marneros AG. Epidermal growth factor deficiency predisposes to progressive renal disease. FASEB J. 2022;36(5):e22286.","journal-title":"FASEB J"},{"issue":"6","key":"4351_CR34","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1172\/JCI114359","volume":"84","author":"HD Humes","year":"1989","unstructured":"Humes HD, Cieslinski DA, Coimbra TM, Messana JM, Galvao C. Epidermal growth factor enhances renal tubule cell regeneration and repair and accelerates the recovery of renal function in postischemic acute renal failure. J Clin Investig. 1989;84(6):1757\u201361.","journal-title":"J Clin Investig"},{"issue":"2","key":"4351_CR35","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1006\/dbio.1995.1164","volume":"169","author":"IIVH Gattone","year":"1995","unstructured":"Gattone IIVH, Lowden DA, Cowley BD Jr. Epidermal growth factor ameliorates autosomal recessive polycystic kidney disease in mice. Dev Biol. 1995;169(2):504\u201310.","journal-title":"Dev Biol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04351-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04351-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04351-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T23:38:37Z","timestamp":1757288317000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04351-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4351"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04351-5","relation":{},"ISSN":["1471-2369"],"issn-type":[{"type":"electronic","value":"1471-2369"}],"subject":[],"published":{"date-parts":[[2025,7,25]]},"assertion":[{"value":"10 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all participants, and the study protocol was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee at Mansoura Faculty of Medicine (Approval number R.24.03.2551).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"416"}}